Scholars agree that aging by itself is an advantageous course of human beings as knowledge and ideas expand. However, this is detrimental as it also slows down other important life aspects such as locomotive and also poses a great risk to the health of individuals. Statistics indicate that age related diseases cause more than a hundred thousand deaths daily. The causes of aging have been a subject of theoretical investigation, with two schools of thoughts competing to explain it.
Since medieval times, aging has been viewed as a programmed action of nature, whereby in biological terms it can be argued that the human DNA is programmed to age over time, by processes such as DNA Methylation. More studies however suggested aging to be a function of accumulated damage such as DNA oxidation. This line of thought has been overcome by the hyper function theorists who observed the effect of calories reduction in rats and its potential advantage to prevent age related diseases. The theorists concluded that aging is a product of continued growth whereby signaling pathways facilitate the process and to know more click here
The paradigm shift meant that it was possible medically to reverse aging or prevent it. Rapamycin is one drug hailed for being effective in this course. This drug targets the immunity system, and clinical trials in 2006 indicated it could cure many diseases related illness. The drug has been applauded by used for credible and observable rejuvenation effects, and its contribution is therefore widely proven. The drug operates by targeting the signaling pathways.
One of the most widely used of Rapamycin drug is Everolimus(Rad001) which was featured in impact journals as having been very efficient in curing age related diseases as well as refreshing the users t youthful settings. This drug was released to the public after approval in the 2006 and has been safely used on transplant patients since then.
The drug has been hailed by Mikhail V Blagosklonny, who concluded from research that Rapamycin drugs possess the future of treating age diseases and cancer. The oncologists and alma mater of St Petersburg’s First Pavlov State Medical University argues that Rapamycin drugs success story ought to be a turning point for medical scholars. He posits that the future of oncology lies in medics stopping targeting aging as an accumulation of harmful molecules to the post effect syndromes they bring on the human body. This would make it very possible to eradicate these effects instead of being overly concerned with the process itself. Roswell Park Cancer Institute’s oncology professor also argues further that Rapamycin has the advantage of strengthening the human body immunity and therefore possess a strong window to expanding the lifespan of human beings.
To know more click here